Politique de santé : Questions médicales fréquentes
Nom anglais: Health Policy
Descriptor UI:D006291
Tree Number:N03.623.500.608.428
Termes MeSH sélectionnés :
Germany
Questions fréquentes et termes MeSH associés
Cadre législatif
5
#1
Qu'est-ce qu'une politique de santé publique ?
C'est un ensemble de décisions visant à améliorer la santé de la population.
Politique de santéSanté publique
#2
Comment les lois influencent-elles la santé ?
Les lois régulent l'accès aux soins, la sécurité alimentaire et l'environnement.
LégislationSanté environnementale
#3
Quel est le rôle des gouvernements en santé ?
Ils établissent des politiques, financent des programmes et régulent les services de santé.
GouvernementServices de santé
#4
Qu'est-ce qu'un système de santé ?
C'est l'ensemble des organisations, institutions et ressources pour fournir des soins.
Système de santéOrganisation des soins
#5
Comment évaluer une politique de santé ?
Par des indicateurs de santé, des études d'impact et des retours d'expérience.
Évaluation des politiquesIndicateurs de santé
Inégalités en santé
5
#1
Quelles sont les causes des inégalités en santé ?
Elles proviennent de facteurs socio-économiques, géographiques et culturels.
Inégalités en santéDéterminants sociaux
#2
Comment mesurer les inégalités en santé ?
Par des indicateurs comme l'espérance de vie, l'accès aux soins et les taux de morbidité.
Mesure des inégalitésIndicateurs de santé
#3
Quel rôle joue l'éducation dans les inégalités en santé ?
L'éducation influence la santé en améliorant les connaissances et l'accès aux ressources.
Éducation en santéDéterminants sociaux
#4
Comment réduire les inégalités en santé ?
Par des politiques ciblées, l'amélioration de l'accès aux soins et l'éducation.
Réduction des inégalitésPolitiques de santé
#5
Quel est l'impact des inégalités sur la société ?
Elles entraînent des coûts économiques élevés et affectent la cohésion sociale.
Impact socialCoûts économiques
Financement de la santé
5
#1
Quelles sont les sources de financement en santé ?
Les impôts, les cotisations sociales, les assurances et les fonds privés.
Financement de la santéAssurance maladie
#2
Quel est l'impact du financement sur l'accès aux soins ?
Un financement adéquat améliore l'accès et la qualité des soins pour la population.
Accès aux soinsÉquité en santé
#3
Comment le budget de santé est-il alloué ?
Il est réparti selon les priorités de santé, les besoins de la population et les urgences.
Budget de santéPlanification des soins
#4
Qu'est-ce que la couverture santé universelle ?
C'est un système garantissant à tous l'accès à des soins de santé sans difficultés financières.
Couverture santé universelleÉquité en santé
#5
Quels défis le financement de la santé rencontre-t-il ?
Les défis incluent le vieillissement de la population, les maladies chroniques et les coûts croissants.
Défis en santéMaladies chroniques
Évaluation des politiques
5
#1
Pourquoi évaluer les politiques de santé ?
Pour mesurer leur efficacité, leur impact et leur pertinence sur la santé publique.
Évaluation des politiquesSanté publique
#2
Quels outils sont utilisés pour l'évaluation ?
Des études de cas, des enquêtes, des analyses statistiques et des revues systématiques.
Outils d'évaluationAnalyse statistique
#3
Comment impliquer les parties prenantes dans l'évaluation ?
En les consultant, en recueillant leurs avis et en intégrant leurs besoins dans l'évaluation.
Parties prenantesConsultation publique
#4
Quelles méthodes d'évaluation sont les plus efficaces ?
Les méthodes mixtes combinant quantitatif et qualitatif offrent une vision complète.
Méthodes d'évaluationRecherche qualitative
#5
Quels sont les résultats attendus d'une évaluation ?
Des recommandations pour améliorer les politiques et des données pour la prise de décision.
Résultats d'évaluationPrise de décision
Prévention et promotion de la santé
5
#1
Qu'est-ce que la promotion de la santé ?
C'est un processus visant à améliorer le bien-être et à prévenir les maladies.
Promotion de la santéPrévention des maladies
#2
Quels sont les principaux programmes de prévention ?
Les programmes de vaccination, de dépistage et d'éducation à la santé.
Programmes de préventionVaccination
#3
Comment sensibiliser la population à la santé ?
Par des campagnes d'information, des ateliers et des ressources éducatives.
Sensibilisation à la santéÉducation à la santé
#4
Quel est le rôle des professionnels de santé en prévention ?
Ils informent, conseillent et encouragent des comportements sains auprès des patients.
Professionnels de santéComportements sains
#5
Pourquoi la prévention est-elle essentielle ?
Elle réduit les coûts de santé, améliore la qualité de vie et prolonge l'espérance de vie.
PréventionCoûts de santé
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Politique de santé : Questions médicales les plus fréquentes",
"headline": "Politique de santé : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Politique de santé : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-13",
"dateModified": "2026-03-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Politique de santé"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Politique publique",
"url": "https://questionsmedicales.fr/mesh/D011640",
"about": {
"@type": "MedicalCondition",
"name": "Politique publique",
"code": {
"@type": "MedicalCode",
"code": "D011640",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Politique nutritionnelle",
"alternateName": "Nutrition Policy",
"url": "https://questionsmedicales.fr/mesh/D018673",
"about": {
"@type": "MedicalCondition",
"name": "Politique nutritionnelle",
"code": {
"@type": "MedicalCode",
"code": "D018673",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.650"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apports nutritionnels recommandés",
"alternateName": "Recommended Dietary Allowances",
"url": "https://questionsmedicales.fr/mesh/D064167",
"about": {
"@type": "MedicalCondition",
"name": "Apports nutritionnels recommandés",
"code": {
"@type": "MedicalCode",
"code": "D064167",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.650.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Contrôle du tabac",
"alternateName": "Tobacco Control",
"url": "https://questionsmedicales.fr/mesh/D000092843",
"about": {
"@type": "MedicalCondition",
"name": "Contrôle du tabac",
"code": {
"@type": "MedicalCode",
"code": "D000092843",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.825"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Politique anti-tabac",
"alternateName": "Smoke-Free Policy",
"url": "https://questionsmedicales.fr/mesh/D061845",
"about": {
"@type": "MedicalCondition",
"name": "Politique anti-tabac",
"code": {
"@type": "MedicalCode",
"code": "D061845",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.825.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prévention du fait de fumer",
"alternateName": "Smoking Prevention",
"url": "https://questionsmedicales.fr/mesh/D000074606",
"about": {
"@type": "MedicalCondition",
"name": "Prévention du fait de fumer",
"code": {
"@type": "MedicalCode",
"code": "D000074606",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.623.500.608.428.825.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Politique de santé",
"alternateName": "Health Policy",
"code": {
"@type": "MedicalCode",
"code": "D006291",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mario R Ortiz",
"url": "https://questionsmedicales.fr/author/Mario%20R%20Ortiz",
"affiliation": {
"@type": "Organization",
"name": "Decker College of Nursing and Health Sciences, Binghamton University, Binghamton, NY, USA."
}
},
{
"@type": "Person",
"name": "Martin McKee",
"url": "https://questionsmedicales.fr/author/Martin%20McKee",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK."
}
},
{
"@type": "Person",
"name": "Scott L Greer",
"url": "https://questionsmedicales.fr/author/Scott%20L%20Greer",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Management and Policy, University of Michigan, Ann Arbor, MI, USA."
}
},
{
"@type": "Person",
"name": "Michelle Falkenbach",
"url": "https://questionsmedicales.fr/author/Michelle%20Falkenbach",
"affiliation": {
"@type": "Organization",
"name": "Department of Public and Ecosystem Health, Cornell University, Ithaca, NY, USA. Electronic address: mfalkenbach@cornell.edu."
}
},
{
"@type": "Person",
"name": "Luigi Siciliani",
"url": "https://questionsmedicales.fr/author/Luigi%20Siciliani",
"affiliation": {
"@type": "Organization",
"name": "Department of Economics and Related Studies, University of York, York, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Advance Care Planning in Germany.",
"datePublished": "2023-06-29",
"url": "https://questionsmedicales.fr/article/37393112",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.zefq.2023.05.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tecovirimat for the treatment of severe Mpox in Germany.",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37273167",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s15010-023-02049-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dataset: a social accounting matrix for Germany.",
"datePublished": "2024-09-12",
"url": "https://questionsmedicales.fr/article/39267197",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13104-024-06925-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Climate change distress and impairment in Germany.",
"datePublished": "2024-09-24",
"url": "https://questionsmedicales.fr/article/39381767",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2024.1432881"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Future Developments in Trauma Care in Germany].",
"datePublished": "2024-08-07",
"url": "https://questionsmedicales.fr/article/39111303",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2349-6196"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Politique (principe)",
"item": "https://questionsmedicales.fr/mesh/D057766"
},
{
"@type": "ListItem",
"position": 4,
"name": "Politiques de régulation sociale",
"item": "https://questionsmedicales.fr/mesh/D011049"
},
{
"@type": "ListItem",
"position": 5,
"name": "Politique publique",
"item": "https://questionsmedicales.fr/mesh/D011640"
},
{
"@type": "ListItem",
"position": 6,
"name": "Politique de santé",
"item": "https://questionsmedicales.fr/mesh/D006291"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Politique de santé - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Politique de santé",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cadre législatif",
"headline": "Cadre législatif sur Politique de santé",
"description": "Qu'est-ce qu'une politique de santé publique ?\nComment les lois influencent-elles la santé ?\nQuel est le rôle des gouvernements en santé ?\nQu'est-ce qu'un système de santé ?\nComment évaluer une politique de santé ?",
"url": "https://questionsmedicales.fr/mesh/D006291?mesh_terms=Germany#section-cadre législatif"
},
{
"@type": "MedicalWebPage",
"name": "Inégalités en santé",
"headline": "Inégalités en santé sur Politique de santé",
"description": "Quelles sont les causes des inégalités en santé ?\nComment mesurer les inégalités en santé ?\nQuel rôle joue l'éducation dans les inégalités en santé ?\nComment réduire les inégalités en santé ?\nQuel est l'impact des inégalités sur la société ?",
"url": "https://questionsmedicales.fr/mesh/D006291?mesh_terms=Germany#section-inégalités en santé"
},
{
"@type": "MedicalWebPage",
"name": "Financement de la santé",
"headline": "Financement de la santé sur Politique de santé",
"description": "Quelles sont les sources de financement en santé ?\nQuel est l'impact du financement sur l'accès aux soins ?\nComment le budget de santé est-il alloué ?\nQu'est-ce que la couverture santé universelle ?\nQuels défis le financement de la santé rencontre-t-il ?",
"url": "https://questionsmedicales.fr/mesh/D006291?mesh_terms=Germany#section-financement de la santé"
},
{
"@type": "MedicalWebPage",
"name": "Évaluation des politiques",
"headline": "Évaluation des politiques sur Politique de santé",
"description": "Pourquoi évaluer les politiques de santé ?\nQuels outils sont utilisés pour l'évaluation ?\nComment impliquer les parties prenantes dans l'évaluation ?\nQuelles méthodes d'évaluation sont les plus efficaces ?\nQuels sont les résultats attendus d'une évaluation ?",
"url": "https://questionsmedicales.fr/mesh/D006291?mesh_terms=Germany#section-évaluation des politiques"
},
{
"@type": "MedicalWebPage",
"name": "Prévention et promotion de la santé",
"headline": "Prévention et promotion de la santé sur Politique de santé",
"description": "Qu'est-ce que la promotion de la santé ?\nQuels sont les principaux programmes de prévention ?\nComment sensibiliser la population à la santé ?\nQuel est le rôle des professionnels de santé en prévention ?\nPourquoi la prévention est-elle essentielle ?",
"url": "https://questionsmedicales.fr/mesh/D006291?mesh_terms=Germany#section-prévention et promotion de la santé"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Qu'est-ce qu'une politique de santé publique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un ensemble de décisions visant à améliorer la santé de la population."
}
},
{
"@type": "Question",
"name": "Comment les lois influencent-elles la santé ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les lois régulent l'accès aux soins, la sécurité alimentaire et l'environnement."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des gouvernements en santé ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils établissent des politiques, financent des programmes et régulent les services de santé."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'un système de santé ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est l'ensemble des organisations, institutions et ressources pour fournir des soins."
}
},
{
"@type": "Question",
"name": "Comment évaluer une politique de santé ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des indicateurs de santé, des études d'impact et des retours d'expérience."
}
},
{
"@type": "Question",
"name": "Quelles sont les causes des inégalités en santé ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles proviennent de facteurs socio-économiques, géographiques et culturels."
}
},
{
"@type": "Question",
"name": "Comment mesurer les inégalités en santé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des indicateurs comme l'espérance de vie, l'accès aux soins et les taux de morbidité."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation dans les inégalités en santé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation influence la santé en améliorant les connaissances et l'accès aux ressources."
}
},
{
"@type": "Question",
"name": "Comment réduire les inégalités en santé ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des politiques ciblées, l'amélioration de l'accès aux soins et l'éducation."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des inégalités sur la société ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles entraînent des coûts économiques élevés et affectent la cohésion sociale."
}
},
{
"@type": "Question",
"name": "Quelles sont les sources de financement en santé ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les impôts, les cotisations sociales, les assurances et les fonds privés."
}
},
{
"@type": "Question",
"name": "Quel est l'impact du financement sur l'accès aux soins ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un financement adéquat améliore l'accès et la qualité des soins pour la population."
}
},
{
"@type": "Question",
"name": "Comment le budget de santé est-il alloué ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est réparti selon les priorités de santé, les besoins de la population et les urgences."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la couverture santé universelle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un système garantissant à tous l'accès à des soins de santé sans difficultés financières."
}
},
{
"@type": "Question",
"name": "Quels défis le financement de la santé rencontre-t-il ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les défis incluent le vieillissement de la population, les maladies chroniques et les coûts croissants."
}
},
{
"@type": "Question",
"name": "Pourquoi évaluer les politiques de santé ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pour mesurer leur efficacité, leur impact et leur pertinence sur la santé publique."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour l'évaluation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études de cas, des enquêtes, des analyses statistiques et des revues systématiques."
}
},
{
"@type": "Question",
"name": "Comment impliquer les parties prenantes dans l'évaluation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "En les consultant, en recueillant leurs avis et en intégrant leurs besoins dans l'évaluation."
}
},
{
"@type": "Question",
"name": "Quelles méthodes d'évaluation sont les plus efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les méthodes mixtes combinant quantitatif et qualitatif offrent une vision complète."
}
},
{
"@type": "Question",
"name": "Quels sont les résultats attendus d'une évaluation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recommandations pour améliorer les politiques et des données pour la prise de décision."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la promotion de la santé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un processus visant à améliorer le bien-être et à prévenir les maladies."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux programmes de prévention ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les programmes de vaccination, de dépistage et d'éducation à la santé."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser la population à la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des campagnes d'information, des ateliers et des ressources éducatives."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des professionnels de santé en prévention ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils informent, conseillent et encouragent des comportements sains auprès des patients."
}
},
{
"@type": "Question",
"name": "Pourquoi la prévention est-elle essentielle ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle réduit les coûts de santé, améliore la qualité de vie et prolonge l'espérance de vie."
}
}
]
}
]
}
Katie Keith, J.D., M.P.H., is an associate research professor at Georgetown University's Center on Health Insurance Reforms and teaches courses on the Affordable Care Act (ACA) and LGBT health law and policy at Georgetown University Law Center. She specializes in ACA implementation and provides "Following the ACA" rapid response analysis for Health Affairs. She is an appointed consumer representative to the National Association of Insurance Commissioners and maintains an active consulting practice, where she advises nonprofits and foundations on health care issues. Ms. Keith received her law degree from Georgetown University Law Center in Washington, DC and holds a Master's in Public Health from Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland. Joel McElvain, J.D., is a partner in the health care practice group of King & Spalding LLP. He previously served as an Assistant Director of the Federal Programs Branch at the U.S. Department of Justice, where he supervised the defense of litigation involving the Department of Health and Human Services. Mr. McElvain participated in the government's defense of numerous cases challenging the constitutionality or implementation of the Affordable Care Act, including National Federation of Independent Business v. Sebelius, 567 U.S. 519 (2012), and King v. Burwell, 135 S. Ct. 2480 (2015). Mr. McElvain received his law degree from Harvard Law School in Cambridge, Massachusetts.
Katie Keith, J.D., M.P.H., is an associate research professor at Georgetown University's Center on Health Insurance Reforms and teaches courses on the Affordable Care Act (ACA) and LGBT health law and policy at Georgetown University Law Center. She specializes in ACA implementation and provides "Following the ACA" rapid response analysis for Health Affairs. She is an appointed consumer representative to the National Association of Insurance Commissioners and maintains an active consulting practice, where she advises nonprofits and foundations on health care issues. Ms. Keith received her law degree from Georgetown University Law Center in Washington, DC and holds a Master's in Public Health from Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland. Joel McElvain, J.D., is a partner in the health care practice group of King & Spalding LLP. He previously served as an Assistant Director of the Federal Programs Branch at the U.S. Department of Justice, where he supervised the defense of litigation involving the Department of Health and Human Services. Mr. McElvain participated in the government's defense of numerous cases challenging the constitutionality or implementation of the Affordable Care Act, including National Federation of Independent Business v. Sebelius, 567 U.S. 519 (2012), and King v. Burwell, 135 S. Ct. 2480 (2015). Mr. McElvain received his law degree from Harvard Law School in Cambridge, Massachusetts.
Department of Surgery, Temple University Health Systems, 3401 N. Broad, Parkinson Pavilion, Suite C405, Philadelphia, PA 19140, USA; Department of General Surgery, Temple University Hospital, 3401 N. Broad, Parkinson Pavilion, Suite C405, Philadelphia, PA 19140, USA.
Department of Surgery, Temple University Health Systems, 3401 N. Broad, Parkinson Pavilion, Suite C405, Philadelphia, PA 19140, USA; Department of General Surgery, Temple University Hospital, 3401 N. Broad, Parkinson Pavilion, Suite C405, Philadelphia, PA 19140, USA.
Advance Care Planning (ACP) defined as a comprehensive concept requiring a cultural change following implementation at the individual, institutional and regional level in order to achieve care consist...
In May 2022, a multi-national mpox outbreak was reported in several non-endemic countries. The only licensed treatment for mpox in the European Union is the orally available small molecule tecovirimat...
We identified presumably all patients with mpox that were treated with tecovirimat in Germany between the onset of the outbreak in May 2022 and March 2023 and obtained demographic and clinical charact...
A total of twelve patients with mpox were treated with tecovirimat in Germany in the study period. All but one patient identified as men who have sex with men (MSM) who were most likely infected with ...
In this cohort of twelve patients with severe mpox, treatment with tecovirimat was well tolerated and all individuals showed clinical improvement....
The Social Accounting Matrix (SAM) is an extension of Input-Output tables that records macro and meso-economic accounts of a socio-economic system. Its main objective is to provide a comprehensive und...
The SAM for Germany is a comprehensive source of data that reveals the incomes and expenditures of 163 different production sectors, along with data on factors of production, households, corporations,...
Climate change has been widely recognized as one of the most challenging problems facing humanity and it imposes serious mental health threats. It is important, however, to differentiate between the a...
Study participants were drawn from a panel which is representative of the German-speaking population in Germany with Internet access. Participants answered a series of questionnaires regarding their c...
Especially women, younger people, people from West Germany, and people with a high level of formal education seem to experience higher levels of climate change distress. Regarding climate change impai...
Climate change distress and impairment are not evenly distributed within German society. The results of this study provide a starting point for the development of target group specific intervention pr...
Trauma surgical care in Germany faces major challenges. The increasing number of cases due to demographic change, combined with reduced bed capacity, requires a rethink in many areas. In order to cont...
Idiopathic Parkinson's disease (IPD) is a progressive neurodegenerative disorder that is strongly associated with age. The aim of the present study was to describe current sex- and age-specific trends...
This study was based on nationwide outpatient claims and drug prescription data from the German Statutory Health Insurance, covering approximately 87% of the general population. We conducted a cohort ...
In 2019, the population at risk comprised 30,575,726 persons. Using the primary and most specific case definition, annual age- and sex-standardized cumulative IPD incidence decreased stepwise from 137...
Our findings indicate a nationwide decline in the age- and sex-standardized incidence of IPD from 2013 to 2019 in Germany. This trend was consistent using different case definitions. Further research ...
Since 2016, quarterly telemedical remote monitoring of patients with an implanted defibrillator or cardiac resynchronization therapy (CRT) system is part of the Einheitlichen Bewertungsmaßstab (EBM, p...
Congenital heart defects (CHD) are still associated with an increased morbidity and mortality. The aim of this study was to analyze trends of mortality rates in patients with CHD between 1998 and 2018...
Data of registered deaths with an underlying diagnosis of CHD were used to evaluate annual mortality between 1998 and 2018. Polynomial regressions were performed to assess annual changes in CHD-associ...
During the 21-year study period, a total of 11,314 deaths were attributed to CHD with 50.9% of deaths in infants (age < 1 year) and 28.2% in neonates (age ≤ 28 days). The most frequent underlying CHDs...
Mortality in CHD patients decreased significantly between 1998 and 2010, but a substantial number of deaths still occurred and even significantly increased in the last 3 years of the observation perio...
Adequate pain management should be part of the standard of care in surgical procedures. However, there is a paucity of data in the field of dermatosurgery. In a standardized online survey among dermat...
Members of the German Society for Dermatosurgery (DGDC) and heads of dermatosurgical departments were asked to participate. Questions were related to practical implementation of perioperative pain man...
116 questionnaires were analyzed. While prophylactic analgesia is rarely used, the vast majority (86%) reported the use of postoperative on-demand medication. The majority of surgeons do not have a fi...
Perioperative pain management in dermatosurgery is strongly influenced by personal experience and may vary depending on the surgery performed. Consensus-based standardized recommendations are lacking....
When cyclists and drivers share the road drivers sometimes try to make the cyclist give way. This study assessed which characteristics and attitudes are related to pushy driving....
The sample included 695 drivers aged 18 to 85 years who answered a German online questionnaire on pushy driving. They saw a sketch with a cyclist in front of them whom they could not overtake easily. ...
Correlations between reported frequency, perceived legitimacy, and perceived effectiveness of pushy driving were between r = 0.78 and r = 0.80. Many correlations with pushy driving were of medium size...
The highest correlations with pushy driving were those with perceived legitimacy and perceived effectiveness of pushy driving. The results show that pushy drivers cannot be identified by demographic c...
There will always be roads that cyclists and drivers share. In order to reduce pushy driving, its legitimacy could be addressed by campaigns and its effectiveness by a lower speed limit and enforcemen...